MANGOCEUTICALS, INC. (Nasdaq:MGRX)
Health Care/Life Sciences • Pharmaceuticals
CIK 1938046
Company
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
Address
15110 North Dallas Parkway
Suite 600
Dallas, Texas 75248
15110 North Dallas Parkway
Suite 600
Dallas, Texas 75248
Employees
3
3
Stock Info
Close
$4.3400
$4.3400
Day Range
4.0300 - 4.4900
4.0300 - 4.4900
52 Week Range
2.0700 - 16.8000
2.0700 - 16.8000
Average volume
100.77K
100.77K
Short Interest
71.47K (02/14/25)
71.47K (02/14/25)
% of Float Shorted
2.97%
2.97%
Market Cap
$21.22M
$21.22M
Revenue
$731.49K
$731.49K
Net Income
-$9.21M
-$9.21M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer Jacob D. Cohen |
President & Director Antonios Isaac |
Independent Director Lorraine D’Alessio |
Independent Director Alex P. Hamilton |
Independent Director Kenny Myers |
SEC filings
Date | Form | Event |
---|---|---|
19 Dec, 2024 | 8-K | |
6 Dec, 2024 | 8-K | |
14 Nov, 2024 | 10-Q | |
12 Nov, 2024 | 8-K | |
12 Nov, 2024 | 4 | |
31 Oct, 2024 | 8-K | |
25 Oct, 2024 | 8-K | |
22 Oct, 2024 | 8-K | |
21 Oct, 2024 | 8-K | |
11 Oct, 2024 | 8-K | |
3 Oct, 2024 | 8-K | |
2 Oct, 2024 | 8-K | |
1 Oct, 2024 | 8-K | |
27 Sep, 2024 | 8-K | |
5 Sep, 2024 | EFFECT | |
3 Sep, 2024 | CORRESP | |
30 Aug, 2024 | AW | |
29 Aug, 2024 | UPLOAD | |
27 Aug, 2024 | SC 13D/A | |
27 Aug, 2024 | 4 | |
23 Aug, 2024 | 8-K | |
16 Aug, 2024 | S-1 | |
15 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
26 Jul, 2024 | POS AM | |
11 Jul, 2024 | 8-K | |
2 Jul, 2024 | 8-K | |
27 Jun, 2024 | 4 | |
24 Jun, 2024 | 144/A | |
20 Jun, 2024 | 144/A | |
18 Jun, 2024 | 144 | |
18 Jun, 2024 | 8-K | |
10 Jun, 2024 | 144 | |
5 Jun, 2024 | 8-K | |
5 Jun, 2024 | 4 | |
5 Jun, 2024 | 4 | |
5 Jun, 2024 | 4 | |
5 Jun, 2024 | 4 | |
5 Jun, 2024 | 4 | |
5 Jun, 2024 | SC 13D/A | |
16 May, 2024 | DEF 14A | |
16 May, 2024 | ARS | |
15 May, 2024 | 10-Q | |
14 May, 2024 | S-8 | |
9 May, 2024 | EFFECT | |
7 May, 2024 | CORRESP | |
6 May, 2024 | S-1/A | |
6 May, 2024 | PRE 14A | |
2 May, 2024 | 8-K | |
30 Apr, 2024 | UPLOAD | |
25 Apr, 2024 | 8-K | |
23 Apr, 2024 | S-1 | |
11 Apr, 2024 | 8-K | |
1 Apr, 2024 | 10-K | |
26 Mar, 2024 | 8-K | |
1 Mar, 2024 | DEF 14A | |
20 Feb, 2024 | PRE 14A | |
25 Jan, 2024 | 8-K | |
23 Jan, 2024 | 8-K | |
2 Jan, 2024 | SC 13D/A | |
2 Jan, 2024 | 8-K | |
29 Dec, 2023 | 4 | |
19 Dec, 2023 | 8-K | |
19 Dec, 2023 | EFFECT | |
18 Dec, 2023 | POS AM | |
15 Dec, 2023 | POS AM | |
14 Dec, 2023 | EFFECT | |
12 Dec, 2023 | S-1/A | |
11 Dec, 2023 | CORRESP | |
11 Dec, 2023 | S-1 | |
11 Dec, 2023 | 8-K | |
11 Dec, 2023 | CORRESP | |
11 Dec, 2023 | CORRESP | |
11 Dec, 2023 | CORRESP | |
30 Nov, 2023 | UPLOAD | |
24 Nov, 2023 | DRS | |
7 Nov, 2023 | 8-K | |
1 Nov, 2023 | 8-K | |
27 Oct, 2023 | 10-Q | |
19 Oct, 2023 | 8-K | |
4 Oct, 2023 | 4 | |
4 Oct, 2023 | 8-K | |
21 Sep, 2023 | 8-K | |
8 Sep, 2023 | 8-K | |
28 Jul, 2023 | 10-Q | |
23 Jun, 2023 | 8-K | |
10 May, 2023 | 10-Q | |
4 May, 2023 | 3 | |
4 May, 2023 | 8-K | |
4 May, 2023 | 4 | |
3 May, 2023 | SC 13D | |
2 May, 2023 | 4 | |
18 Apr, 2023 | S-8 | |
29 Mar, 2023 | SEC STAFF | |
22 Mar, 2023 | 424B4 | IPO completed |
22 Mar, 2023 | 424B4 | |
21 Mar, 2023 | CERT | |
21 Mar, 2023 | 3 | |
20 Mar, 2023 | 3 | |
20 Mar, 2023 | 3 | |
20 Mar, 2023 | 3 | |
20 Mar, 2023 | EFFECT | |
20 Mar, 2023 | 3 | |
20 Mar, 2023 | 3 | |
17 Mar, 2023 | CORRESP | |
17 Mar, 2023 | CORRESP | |
17 Mar, 2023 | CORRESP | |
17 Mar, 2023 | CORRESP | |
14 Mar, 2023 | CORRESP | |
14 Mar, 2023 | CORRESP | |
28 Feb, 2023 | CORRESP | |
28 Feb, 2023 | S-1/A | |
24 Feb, 2023 | UPLOAD | |
22 Feb, 2023 | CORRESP | |
22 Feb, 2023 | CORRESP | |
21 Feb, 2023 | S-1/A | |
10 Feb, 2023 | CORRESP | |
10 Feb, 2023 | CORRESP | |
6 Feb, 2023 | S-1/A | |
6 Feb, 2023 | 8-A12B | |
3 Feb, 2023 | CORRESP | |
1 Feb, 2023 | UPLOAD | |
26 Jan, 2023 | S-1/A | |
24 Jan, 2023 | SEC STAFF | |
13 Jan, 2023 | S-1 | |
22 Dec, 2022 | DRSLTR | |
21 Dec, 2022 | DRS/A | |
20 Dec, 2022 | DRSLTR | |
9 Dec, 2022 | UPLOAD | |
18 Nov, 2022 | DRS/A | |
17 Nov, 2022 | DRSLTR | |
27 Oct, 2022 | UPLOAD | |
11 Oct, 2022 | D/A | |
26 Sep, 2022 | DRS | |
31 Aug, 2022 | D |
Last update:2025-03-06 12:33:22.281347
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.